menu search

Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference

Design Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
CARLSBAD, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that João Siffert, M.D., president and chief executive officer, will participate in a fireside chat during the SVB Securities Virtual Global Biopharma Conference on Wednesday, February 15, 2023, at […] The post Design Therapeutics to Participate in the SVB Securities Virtual Global Biop... Read More
Posted: Feb 8 2023, 11:30
Author Name: forextv
Views: 102874

Search within

Pages Search Results: